Travere Therapeutics, Inc.

Pharmaceutical company · San Diego, California, United States · Nasdaq: TVTX

Travere Therapeutics, Inc. is a pharmaceutical company headquartered in San Diego, California, United States. Its shares trade on Nasdaq under the ticker TVTX. It has reported private securities offerings to the US SEC, most recently $25 million sold in a notice filed in 2013.

Profile compiled from public records. Is this your company? Request a correction or update

Travere Therapeutics at a glance

Typepharmaceutical company
HeadquartersSan Diego, California, United States
Stock listingNasdaq: TVTX
SEC industryPharmaceutical Preparations
SEC CIK1438533

What does Travere Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $24.9 million sold (2013).

Frequently asked questions about Travere Therapeutics

Where is Travere Therapeutics headquartered?

Travere Therapeutics, Inc. is headquartered in San Diego, California, United States.

What does Travere Therapeutics do?

Travere Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Travere Therapeutics a public company?

Yes. Travere Therapeutics, Inc. trades on Nasdaq under the ticker TVTX.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.